跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 375 条关于
“HABP/VABP”
全部
375
临床试验
272
药物
65
机构
1
资讯
37
2个月前
FDA Accepts Shionogi's sNDA for Fetroja (Cefiderocol) in Pediatric Patients with Serious Gram-Negative Infections
去年
Advancements in Antibiotic Development for Gram-Negative Bacteria
5个月前
Shionogi Secures $482 Million BARDA Contract to Strengthen U.S. Biodefense Against Drug-Resistant Bacterial Threats
2个月前
Telum Therapeutics Secures €18 Million Series A to Advance Novel Antimicrobial Against Acinetobacter baumannii
去年
Spero Therapeutics' Tebipenem HBr Phase 3 Trial Enrollment Nears Completion
去年
Spero Therapeutics Halts SPR720 Development After Phase II Failure, Focuses on Tebipenem HBr and SPR206
去年
Spero Therapeutics Halts SPR720 Development After Phase IIa Failure
去年
Spero Therapeutics Halts SPR720 Development After Phase 2a Trial Fails to Meet Primary Endpoint
7个月前
Acurx Pharmaceuticals Secures New Patent for DNA Polymerase IIIC Inhibitors Targeting Antibiotic-Resistant Bacteria
11个月前
Acurx Pharmaceuticals Secures Australian Patent for Novel DNA Polymerase IIIC Inhibitor Antibiotics
第 1 页,共 4 页
上一页
下一页